There’s plenty for bulls and bears to hash out over Palantir Technologies (PLTR), a maker of data analytics software. The outlook for federal government deals is one issue for PLTR stock. Then, there’s growth from new artificial intelligence products to mull for Palantir stock.
Meanwhile, earnings for PLTR stock are due May 5. Ahead of the earnings report, Palantir stock has formed a new cup base.
In Q1, Wall Street analysts project adjusted EPS of 13 cents, up 65% from a year earlier, with revenue climbing 36% to $862.2 million.
Heading into the Q1 Palantir earnings report, UBS analyst Karl Kierstead holds a neutral rating.
“Bottom line, Palantir seems very resilient, with the one key risk being that the company is exposed to federal government deal delays that our checks argue are happening today … Palantir has already hinted that Fed uncertainty could result in more second-half-weighted U.S. government deal awards. Our checks were clear that this is indeed happening but that Palantir is on the right side of a DoD/government spending mix shift (more software/AI, less hardware/equipment).”
Meanwhile, a basic options trading strategy around earnings — using call options — allows investors to buy a stock at a predetermined price without taking a lot of risk.
Amid stock market volatility from President Donald Trump’s tariff-based trade policy, Palantir stock has gained 49% in 2025.
Further, PLTR stock hit its all-time intraday high of 125.41 on Feb. 19. Shares have retreated 10% from that high. But PLTR stock trades above its 50-day moving average, a key technical level.
Also, Palantir has outperformed other software stocks. The iShares Expanded Tech-Software Sector ETF (IGV), an industry index that includes many big-cap software companies, is down 5% in 2025.
Further, Palantir joined the Nasdaq 100 index in December.
PLTR Stock Fundamentals
Palantir has provided data analytics tools to government customers for intelligence gathering, counterterrorism, and military purposes. Now Palantir aims to use generative AI to spur growth in the U.S. commercial market, such as health care and financial services.
